The insurer (also known as Elevance) first launched its new “nonparticipating care providers” policy across 11 states beginning on Jan. 1, drawing widespread criticism.
The risk associated with under-recognized CKD emerged early, highlighting the need for screening soon after a CAD diagnosis so that cardio-renal protective drugs can be started much earlier.
The organization has grown significantly in recent years, and like similar imaging groups, faced mounting challenges in automating core front-office functions, verifying insurance benefits and helping staff struggling to keeping up with it all.
The past 12 months have brought numerous exciting advances involving AI and related emerging technologies. Let us not fail to take a short last look at some of the more spectacular flops.
